Medicine Technology 🌱 Environment Space Energy Physics Engineering Social Science Earth Science Science
Medicine 2026-03-12 4 min read

Traditional Medicine Serves 80% of the World, but Integration with Modern Care Remains Uneven

A global review maps how countries are combining indigenous healing practices with biomedical systems and identifies persistent barriers from regulatory gaps to epistemological clashes

Xia & He Publishing Inc.

More than 80% of the global population uses some form of traditional medicine - practices rooted in indigenous knowledge systems that predate and often run parallel to the biomedical model. In India, over 750,000 AYUSH practitioners work within the national healthcare system. In China, traditional Chinese medicine operates alongside biomedicine in hospitals. In Africa, up to 80% of the population relies on traditional healers for primary care.

Yet the integration of these systems with modern medicine remains fragmented, contentious, and uneven. A review published in Future Integrative Medicine maps the global landscape and finds a complex picture: real progress in some regions, deep structural barriers in others, and fundamental disagreements about what counts as evidence.

The regional scorecard

Asia leads in state-driven integration. India's AYUSH system (Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy) is formally embedded in national healthcare, with services co-located in thousands of public facilities. South Korea operates a dual system under national insurance. Japan integrates Kampo medicine within its insurance framework. Thailand and Bhutan have institutionalized traditional practices into public healthcare systems.

Africa has seen rapid policy development - WHO African Region member states with traditional medicine policies grew from 8 in 2000 to 40 in 2020 - but regulatory enforcement remains inconsistent. Countries like South Africa, Ghana, and Nigeria have established frameworks and research institutions, but implementation lags behind the policy language.

Europe presents a patchwork. Germany reports 40% of adults using complementary and alternative medicine (CAM). Switzerland includes complementary medicine in basic health insurance. The UK maintains specialized facilities like the Royal London Hospital for Integrated Medicine. But regulatory discrepancies between countries and ongoing debates about scientific validation create friction.

In North America, CAM use reached 47.9% of U.S. adults in 2019, with out-of-pocket spending hitting $30.2 billion. Academic centers like Harvard's Osher Center lead integration research. Canada has begun incorporating Indigenous traditional healing into medical education.

Latin America and the Caribbean serve over 400 million traditional medicine users with an estimated $3 billion in annual spending. Cuba and Brazil lead in formal integration through national programs supporting acupuncture, homeopathy, and phytotherapy within public health systems.

The philosophical collision

The deepest barrier to integration is not regulatory or financial - it is epistemological. Traditional medicine systems operate from holistic frameworks that view health as a balance of interconnected forces. Modern biomedicine operates from a reductionist model that isolates specific mechanisms and tests them through randomized controlled trials (RCTs).

These approaches answer different questions in different ways. An RCT can determine whether a specific compound reduces blood pressure in a defined population over 12 weeks. It is less well-suited to evaluating a traditional practice that uses multiple herbs in combination, tailored to individual patients, and assessed by criteria like energy balance or constitutional harmony that do not map neatly onto biomedical endpoints.

The review argues for methodological pluralism - combining RCTs with pragmatic trials, n-of-1 studies (single-patient experiments), and real-world evidence. This is a reasonable position but one that remains controversial in regulatory and academic circles where RCTs are considered the gold standard.

Standardization, safety, and intellectual property

Beyond philosophy, practical challenges abound. Quality control and standardization of traditional medicines are inconsistent. Herbal preparations can vary widely in potency, purity, and composition depending on growing conditions, harvesting methods, and processing techniques. Herb-drug interactions are poorly studied, and pharmacovigilance systems for traditional medicines are weak in most countries.

Intellectual property presents another thorny problem. Traditional knowledge often belongs to communities rather than individuals, and existing patent systems are poorly equipped to protect it. The review calls for sui generis (purpose-built) legal systems and benefit-sharing arrangements, but such frameworks remain rare in practice.

What the review proposes

The authors outline a strategic roadmap that includes strengthened global leadership through the WHO's Global Centre for Traditional Medicine in India, increased research funding with interdisciplinary review panels, education reform integrating traditional medicine into both traditional and conventional medical curricula, regulatory harmonization across countries, and community engagement that respects cultural contexts.

The limitations of a review this broad

A review covering traditional medicine integration across every global region necessarily trades depth for breadth. The treatment of each region is brief, and the challenges specific to individual countries or healing traditions are inevitably simplified. The review draws heavily on published literature and policy documents, which may not reflect on-the-ground realities in many communities.

The review also does not systematically assess the clinical evidence for traditional medicine practices themselves. Whether specific traditional treatments are effective for specific conditions is a separate and enormous body of literature that this paper does not engage with. The focus is on integration models and barriers, not therapeutic efficacy.

And the aspirational tone of the strategic roadmap, while useful for setting direction, does not grapple deeply with the political and economic forces that have historically blocked integration efforts. Regulatory harmonization, intellectual property reform, and methodological pluralism are each multi-decade challenges on their own.

Still, as a map of the current landscape, the review serves a useful function: showing how differently countries around the world are approaching the same fundamental question of how to combine healing traditions that operate from different premises about what health means and how to achieve it.

Source: Published in Future Integrative Medicine, 2026. DOI link: https://www.xiahepublishing.com/2835-6357/FIM-2025-00040. Published by Xia & He Publishing Inc., official journal of Capital Medical University.